About Ribosomal L1 domain-containing protein 1
Ribosomal L1 domain-containing protein 1 (RSL1D1) is a protein
from Homo sapiens identified by UniProt accession
O76021, 490 residues long.
MolForge cross-references it against 0 known binders and
32 disease associations.
Target properties
| Protein name | Ribosomal L1 domain-containing protein 1 |
| UniProt accession | O76021 |
| Gene | RSL1D1 |
| Organism | Homo sapiens |
| Length | 490 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (32)
Diseases linked to this target (Open Targets).
- red blood cell density measurement · score 0.14
- hemoglobin measurement · score 0.14
- Testicular Germ Cell Tumor · score 0.13
- heel bone mineral density · score 0.13
- age at menopause · score 0.11
- adolescent idiopathic scoliosis · score 0.11
- erythrocyte count · score 0.11
- hepatocellular carcinoma · score 0.10
- neoplasm · score 0.09
- hematocrit · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O76021-F1 | alphafold | PREDICTED | 66.75 | — |
Amino-acid sequence (490 residues)
MEDSASASLS SAAATGTSTS TPAAPTARKQ LDKEQVRKAV DALLTHCKSR KNNYGLLLNE NESLFLMVVL WKIPSKELRV RLTLPHSIRS DSEDICLFTK DEPNSTPEKT EQFYRKLLNK HGIKTVSQII SLQTLKKEYK SYEAKLRLLS SFDFFLTDAR IRRLLPSLIG RHFYQRKKVP VSVNLLSKNL SREINDCIGG TVLNISKSGS CSAIRIGHVG MQIEHIIENI VAVTKGLSEK LPEKWESVKL LFVKTEKSAA LPIFSSFVSN WDEATKRSLL NKKKKEARRK RRERNFEKQK ERKKKRQQAR KTASVLSKDD VAPESGDTTV KKPESKKEQT PEHGKKKRGR GKAQVKATNE SEDEIPQLVP IGKKTPANEK VEIQKHATGK KSPAKSPNPS TPRGKKRKAL PASETPKAAE SETPGKSPEK KPKIKEEAVK EKSPSLGKKD ARQTPKKPEA KFFTTPSKSV RKASHTPKKW PKKPKVPQST
Explore Ribosomal L1 domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets